Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 214

1.

Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation.

Cohen JA, Baldassari LE, Atkins HL, Bowen JD, Bredeson C, Carpenter PA, Corboy JR, Freedman MS, Griffith LM, Lowsky R, Majhail NS, Muraro PA, Nash RA, Pasquini MC, Sarantopoulos S, Savani BN, Storek J, Sullivan KM, Georges GE.

Biol Blood Marrow Transplant. 2019 May;25(5):845-854. doi: 10.1016/j.bbmt.2019.02.014. Epub 2019 Feb 19. Review.

2.

Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation.

Sullivan KM, Majhail NS, Bredeson C, Carpenter PA, Chatterjee S, Crofford LJ, Georges GE, Nash RA, Pasquini MC, Sarantopoulos S, Storek J, Savani B, St Clair EW.

Biol Blood Marrow Transplant. 2018 Oct;24(10):1961-1964. doi: 10.1016/j.bbmt.2018.06.025. Epub 2018 Jun 25.

PMID:
29953945
3.

Reasons to Doubt the Reliability of Eyewitness Memory: Commentary on Wixted, Mickes, and Fisher (2018).

Wade KA, Nash RA, Lindsay DS.

Perspect Psychol Sci. 2018 May;13(3):339-342. doi: 10.1177/1745691618758261.

PMID:
29716452
4.

A memory advantage for past-oriented over future-oriented performance feedback.

Nash RA, Winstone NE, Gregory SEA, Papps E.

J Exp Psychol Learn Mem Cogn. 2018 Dec;44(12):1864-1879. doi: 10.1037/xlm0000549. Epub 2018 Mar 5.

PMID:
29504785
5.

False memories, nonbelieved memories, and the unresolved primacy of communication.

Nash RA.

Behav Brain Sci. 2018 Jan;41:e25. doi: 10.1017/S0140525X17001455.

PMID:
29353584
6.

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.

Sullivan KM, Goldmuntz EA, Keyes-Elstein L, McSweeney PA, Pinckney A, Welch B, Mayes MD, Nash RA, Crofford LJ, Eggleston B, Castina S, Griffith LM, Goldstein JS, Wallace D, Craciunescu O, Khanna D, Folz RJ, Goldin J, St Clair EW, Seibold JR, Phillips K, Mineishi S, Simms RW, Ballen K, Wener MH, Georges GE, Heimfeld S, Hosing C, Forman S, Kafaja S, Silver RM, Griffing L, Storek J, LeClercq S, Brasington R, Csuka ME, Bredeson C, Keever-Taylor C, Domsic RT, Kahaleh MB, Medsger T, Furst DE; SCOT Study Investigators.

N Engl J Med. 2018 Jan 4;378(1):35-47.

7.

Responsibility-Sharing in the Giving and Receiving of Assessment Feedback.

Nash RA, Winstone NE.

Front Psychol. 2017 Sep 6;8:1519. doi: 10.3389/fpsyg.2017.01519. eCollection 2017. Review.

8.

Changing beliefs about past public events with believable and unbelievable doctored photographs.

Nash RA.

Memory. 2018 Apr;26(4):439-450. doi: 10.1080/09658211.2017.1364393. Epub 2017 Aug 17.

PMID:
28814176
9.

The Use of Ex Vivo Generated Regulatory T-Cell Preparations in a Canine Lung Allograft Model.

Abrams KV, Hwang B, Nash RA, Georges GE, Lamm W, Storer B, Madtes DK, Glenny R, Mulligan MS.

Transplantation. 2017 Oct;101(10):e326-e327. doi: 10.1097/TP.0000000000001868. No abstract available.

10.

Manufacture of Autologous CD34+ Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune Diseases.

Keever-Taylor CA, Heimfeld S, Steinmiller KC, Nash RA, Sullivan KM, Czarniecki CW, Granderson TC, Goldstein JS, Griffith LM.

Biol Blood Marrow Transplant. 2017 Sep;23(9):1463-1472. doi: 10.1016/j.bbmt.2017.05.018. Epub 2017 Jun 30.

11.

Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.

Muraro PA, Pasquini M, Atkins HL, Bowen JD, Farge D, Fassas A, Freedman MS, Georges GE, Gualandi F, Hamerschlak N, Havrdova E, Kimiskidis VK, Kozak T, Mancardi GL, Massacesi L, Moraes DA, Nash RA, Pavletic S, Ouyang J, Rovira M, Saiz A, Simoes B, Trnený M, Zhu L, Badoglio M, Zhong X, Sormani MP, Saccardi R; Multiple Sclerosis–Autologous Hematopoietic Stem Cell Transplantation (MS-AHSCT) Long-term Outcomes Study Group.

JAMA Neurol. 2017 Apr 1;74(4):459-469. doi: 10.1001/jamaneurol.2016.5867.

12.

Misrepresentations and Flawed Logic About the Prevalence of False Memories.

Nash RA, Wade KA, Garry M, Loftus EF, Ost J.

Appl Cogn Psychol. 2017 Jan-Feb;31(1):31-33. doi: 10.1002/acp.3265. Epub 2016 Oct 14.

13.

High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS.

Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Steinmiller KC, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Stuve O, Arnold DL, Wener MH, Georges GE, Wundes A, Kraft GH, Bowen JD.

Neurology. 2017 Feb 28;88(9):842-852. doi: 10.1212/WNL.0000000000003660. Epub 2017 Feb 1.

14.

Brain pathology of a patient 7years after autologous hematopoietic stem cell transplantation for multiple sclerosis.

Wundes A, Bowen JD, Kraft GH, Maravilla KR, McLaughlin B, von Geldern G, Georges G, Nash RA, Lu JQ.

J Neurol Sci. 2017 Feb 15;373:339-341. doi: 10.1016/j.jns.2017.01.016. Epub 2017 Jan 7.

PMID:
28131217
15.

Public Attitudes on the Ethics of Deceptively Planting False Memories to Motivate Healthy Behavior.

Nash RA, Berkowitz SR, Roche S.

Appl Cogn Psychol. 2016 Nov-Dec;30(6):885-897. doi: 10.1002/acp.3274. Epub 2016 Sep 21.

16.

When is an image a health claim? A false-recollection method to detect implicit inferences about products' health benefits.

Klepacz NA, Nash RA, Egan MB, Hodgkins CE, Raats MM.

Health Psychol. 2016 Aug;35(8):898-907. doi: 10.1037/hea0000317.

PMID:
27505213
17.

A robust preference for cheap-and-easy strategies over reliable strategies when verifying personal memories.

Nash RA, Wade KA, Garry M, Adelman JS.

Memory. 2017 Aug;25(7):890-899. doi: 10.1080/09658211.2016.1214280. Epub 2016 Aug 2.

PMID:
27484874
18.

Sub-types of nonbelieved memories reveal differential outcomes of challenges to memories.

Scoboria A, Nash RA, Mazzoni G.

Memory. 2017 Aug;25(7):876-889. doi: 10.1080/09658211.2016.1203437. Epub 2016 Jul 11.

PMID:
27402307
19.

Truthiness and falsiness of trivia claims depend on judgmental contexts.

Newman EJ, Garry M, Unkelbach C, Bernstein DM, Lindsay DS, Nash RA.

J Exp Psychol Learn Mem Cogn. 2015 Sep;41(5):1337-48. doi: 10.1037/xlm0000099. Epub 2015 Mar 30.

PMID:
25822783
20.

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report.

Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Stüve O, Arnold DL, Spychala ME, McConville KC, Harris KM, Phippard D, Georges GE, Wundes A, Kraft GH, Bowen JD.

JAMA Neurol. 2015 Feb;72(2):159-69. doi: 10.1001/jamaneurol.2014.3780.

21.

On the persuadability of memory: Is changing people's memories no more than changing their minds?

Nash RA, Wheeler RL, Hope L.

Br J Psychol. 2015 May;106(2):308-26. doi: 10.1111/bjop.12074. Epub 2014 Jun 4. Review.

PMID:
24898340
22.

Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation.

Castilla-Llorente C, Martin PJ, McDonald GB, Storer BE, Appelbaum FR, Deeg HJ, Mielcarek M, Shulman H, Storb R, Nash RA.

Bone Marrow Transplant. 2014 Jul;49(7):966-71. doi: 10.1038/bmt.2014.69. Epub 2014 Apr 28.

23.

T cell repertoire following autologous stem cell transplantation for multiple sclerosis.

Muraro PA, Robins H, Malhotra S, Howell M, Phippard D, Desmarais C, de Paula Alves Sousa A, Griffith LM, Lim N, Nash RA, Turka LA.

J Clin Invest. 2014 Mar;124(3):1168-72. doi: 10.1172/JCI71691. Epub 2014 Feb 17.

24.

People consider reliability and cost when verifying their autobiographical memories.

Wade KA, Nash RA, Garry M.

Acta Psychol (Amst). 2014 Feb;146:28-34. doi: 10.1016/j.actpsy.2013.12.001. Epub 2013 Dec 25.

PMID:
24370787
25.

Disowned recollections: denying true experiences undermines belief in occurrence but not judgments of remembering.

Mazzoni G, Clark A, Nash RA.

Acta Psychol (Amst). 2014 Jan;145:139-46. doi: 10.1016/j.actpsy.2013.11.007. Epub 2013 Dec 15.

PMID:
24345675
26.

Priming moral self-ambivalence heightens deliberative behaviour in self-ambivalent individuals.

Perera-Delcourt R, Nash RA, Thorpe SJ.

Behav Cogn Psychother. 2014 Nov;42(6):682-92. doi: 10.1017/S1352465813000507. Epub 2013 Sep 27.

PMID:
24073879
27.

Late infusion of cloned marrow fibroblasts stimulates endogenous recovery from radiation-induced lung injury.

Iwata M, Madtes DK, Abrams K, Lamm WJ, Glenny RW, Nash RA, Ramakrishnan A, Torok-Storb B.

PLoS One. 2013;8(3):e57179. doi: 10.1371/journal.pone.0057179. Epub 2013 Mar 8.

28.

Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trial.

Hung EW, Mayes MD, Sharif R, Assassi S, Machicao VI, Hosing C, St Clair EW, Furst DE, Khanna D, Forman S, Mineishi S, Phillips K, Seibold JR, Bredeson C, Csuka ME, Nash RA, Wener MH, Simms R, Ballen K, Leclercq S, Storek J, Goldmuntz E, Welch B, Keyes-Elstein L, Castina S, Crofford LJ, Mcsweeney P, Sullivan KM.

J Rheumatol. 2013 Apr;40(4):455-60. doi: 10.3899/jrheum.121087. Epub 2013 Feb 15.

29.

False recognition of objects in visual scenes: findings from a combined direct and indirect memory test.

Weinstein Y, Nash RA.

Mem Cognit. 2013 Jan;41(1):60-8. doi: 10.3758/s13421-012-0242-0.

PMID:
22976882
30.

Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research.

Pasquini MC, Voltarelli J, Atkins HL, Hamerschlak N, Zhong X, Ahn KW, Sullivan KM, Carrum G, Andrey J, Bredeson CN, Cairo M, Gale RP, Hahn T, Storek J, Horowitz MM, McSweeney PA, Griffith LM, Muraro PA, Pavletic SZ, Nash RA.

Biol Blood Marrow Transplant. 2012 Oct;18(10):1471-8. doi: 10.1016/j.bbmt.2012.06.003. Epub 2012 Jun 13.

31.

Creating non-believed memories for recent autobiographical events.

Clark A, Nash RA, Fincham G, Mazzoni G.

PLoS One. 2012;7(3):e32998. doi: 10.1371/journal.pone.0032998. Epub 2012 Mar 9.

32.

Tolerance to vascularized composite allografts in canine mixed hematopoietic chimeras.

Mathes DW, Hwang B, Graves SS, Edwards J, Chang J, Storer BE, Butts-Miwongtum T, Sale GE, Nash RA, Storb R.

Transplantation. 2011 Dec 27;92(12):1301-8. doi: 10.1097/TP.0b013e318237d6d4.

33.

Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results.

Bowen JD, Kraft GH, Wundes A, Guan Q, Maravilla KR, Gooley TA, McSweeney PA, Pavletic SZ, Openshaw H, Storb R, Wener M, McLaughlin BA, Henstorf GR, Nash RA.

Bone Marrow Transplant. 2012 Jul;47(7):946-51. doi: 10.1038/bmt.2011.208. Epub 2011 Nov 7.

34.

Shared cognitive processes underlying past and future thinking: the impact of imagery and concurrent task demands on event specificity.

Anderson RJ, Dewhurst SA, Nash RA.

J Exp Psychol Learn Mem Cogn. 2012 Mar;38(2):356-65. doi: 10.1037/a0025451. Epub 2011 Sep 19.

PMID:
21928933
35.

Reconstructing alcohol-induced memory blackouts.

Nash RA, Takarangi MK.

Memory. 2011 Aug;19(6):566-73. doi: 10.1080/09658211.2011.590508.

PMID:
21919584
36.

A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells.

Inamoto Y, Flowers ME, Appelbaum FR, Carpenter PA, Deeg HJ, Furlong T, Kiem HP, Mielcarek M, Nash RA, Storb RF, Witherspoon RP, Storer BE, Martin PJ.

Biol Blood Marrow Transplant. 2011 Jul;17(7):1088-92. doi: 10.1016/j.bbmt.2011.01.017. Epub 2011 Mar 21.

37.

Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.

Flowers ME, Inamoto Y, Carpenter PA, Lee SJ, Kiem HP, Petersdorf EW, Pereira SE, Nash RA, Mielcarek M, Fero ML, Warren EH, Sanders JE, Storb RF, Appelbaum FR, Storer BE, Martin PJ.

Blood. 2011 Mar 17;117(11):3214-9. doi: 10.1182/blood-2010-08-302109. Epub 2011 Jan 24.

38.

Crohn disease: remissions but no cure.

Nash RA, McDonald GB.

Blood. 2010 Dec 23;116(26):5790-1. doi: 10.1182/blood-2010-09-309252. No abstract available.

39.

Autologous hematopoietic cell transplantation for multiple sclerosis: a systematic review.

Reston JT, Uhl S, Treadwell JR, Nash RA, Schoelles K.

Mult Scler. 2011 Feb;17(2):204-13. doi: 10.1177/1352458510383609. Epub 2010 Oct 4. Review.

PMID:
20921236
40.

Mesenchymal stromal cells fail to prevent acute graft-versus-host disease and graft rejection after dog leukocyte antigen-haploidentical bone marrow transplantation.

Mielcarek M, Storb R, Georges GE, Golubev L, Nikitine A, Hwang B, Nash RA, Torok-Storb B.

Biol Blood Marrow Transplant. 2011 Feb;17(2):214-25. doi: 10.1016/j.bbmt.2010.08.015. Epub 2010 Oct 30.

41.

Mitoxantrone for worsening multiple sclerosis: tolerability, toxicity, adherence and efficacy in the clinical setting.

Wundes A, Kraft GH, Bowen JD, Gooley TA, Nash RA.

Clin Neurol Neurosurg. 2010 Dec;112(10):876-82. doi: 10.1016/j.clineuro.2010.07.018. Epub 2010 Aug 19.

PMID:
20727669
42.

Neuroinflammation and demyelination in multiple sclerosis after allogeneic hematopoietic stem cell transplantation.

Lu JQ, Joseph JT, Nash RA, Storek J, Stevens AM, Metz LM, Clark AW, Johnson ES, Yong VW.

Arch Neurol. 2010 Jun;67(6):716-22. doi: 10.1001/archneurol.2010.117.

PMID:
20558390
43.

Look who's talking! Facial appearance can bias source monitoring.

Nash RA, Bryer OM, Schlaghecken F.

Memory. 2010 May;18(4):451-7. doi: 10.1080/09658211003742706. Epub 2010 Apr 19.

PMID:
20408040
44.

Outcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic anemia in patients over 40 years of age.

Sangiolo D, Storb R, Deeg HJ, Flowers ME, Martin PJ, Sandmaier BM, Kiem HP, Nash RA, Doney K, Leisenring WM, Georges GE.

Biol Blood Marrow Transplant. 2010 Oct;16(10):1411-8. doi: 10.1016/j.bbmt.2010.04.005. Epub 2010 Apr 18.

45.

A preclinical model of double- versus single-unit unrelated cord blood transplantation.

Georges GE, Lesnikov V, Baran SW, Aragon A, Lesnikova M, Jordan R, Laura Yang YJ, Yunusov MY, Zellmer E, Heimfeld S, Venkataraman GM, Harkey MA, Graves SS, Storb R, Storer BE, Nash RA.

Biol Blood Marrow Transplant. 2010 Aug;16(8):1090-8. doi: 10.1016/j.bbmt.2010.03.010. Epub 2010 Mar 18.

46.

Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies.

Pasquini MC, Griffith LM, Arnold DL, Atkins HL, Bowen JD, Chen JT, Freedman MS, Kraft GH, Mancardi GL, Martin R, Muraro PA, Nash RA, Racke MK, Storek J, Saccardi R.

Biol Blood Marrow Transplant. 2010 Aug;16(8):1076-83. doi: 10.1016/j.bbmt.2010.03.012. Epub 2010 Mar 18. Review.

47.

Anchoring effects in the development of false childhood memories.

Wade KA, Garry M, Nash RA, Harper DN.

Psychon Bull Rev. 2010 Feb;17(1):66-72. doi: 10.3758/PBR.17.1.66.

PMID:
20081163
48.

A novel monoclonal antibody specific for canine CD25 (P4A10): selection and evaluation of canine Tregs.

Abrams VK, Hwang B, Lesnikova M, Gass MJ, Wayner E, Castilla-Llorente C, Georges GE, Nash RA.

Vet Immunol Immunopathol. 2010 Jun 15;135(3-4):257-65. doi: 10.1016/j.vetimm.2009.12.006. Epub 2009 Dec 29.

49.

Thymoglobulin and cyclophosphamide as treatment for diffuse cutaneous systemic sclerosis.

Holmberg LA, Furst DE, McSweeney PA, Nash RA.

J Rheumatol. 2009 Aug;36(8):1839. doi: 10.3899/jrheum.081268. No abstract available.

PMID:
19671826
50.

Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis.

Fleming JN, Shulman HM, Nash RA, Johnson PY, Wight TN, Gown A, Schwartz SM.

PLoS One. 2009 Jul 9;4(7):e6203. doi: 10.1371/journal.pone.0006203.

Supplemental Content

Support Center